<DOC>
	<DOCNO>NCT02925923</DOCNO>
	<brief_summary>The purpose study compare inhibition platelet aggregation ( ) ticagrelor bivalirudin/heparin versus ( ii ) clopidogrel , eptifibatide heparin patient unstable angina undergoing coronary intervention .</brief_summary>
	<brief_title>Ticagrelor Versus Clopidogrel Eptifibatide Bolus</brief_title>
	<detailed_description>The first 30 minute PCI procedure outmost importance plaque rupture platelet activation occur . Platelet activation accumulation cause formation blood clot may cause heart attack . As standard care , doctor prescribe medication ticagrelor , eptifibatide , clopidogrel , prevent formation blood clot . 100 patient stable unstable angina , male female , randomize either Group A- Ticagrelor bivalirudin/heparin Group B- Clopidogrel , eptifibatide heparin administrate immediately PCI . Platelet function test ECG perform .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Eptifibatide</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>Patients stable unstable angina . 1. need oral anticoagulation therapy ( Warfarin , Dabigatran , Rivaroxaban , Apixaban , Edoxaban ) 2. increase risk bradycardia , associate therapy strong cytochrome P450 inhibitor ( antiretroviral agent , antifungal agent antibiotic eg . Indinavir , Nelfinavir , Lopinavir , Ritonavir , Itraconazole , Ketoconazole , Voriconazole , Clarithromycin , Telithormycin ) 3. surgery &lt; 4 week 4. use thienopyridines ( Clopidogrel , Prasugrel ) 7 day prior randomization 5. administration GP IIb/IIIa inhibitor 6. bleed diathesis major bleed episode within 2 week 7. thrombocytopenia ( Platelet count &lt; 100000 ) 8. incessant chest pain 9. hemodynamic instability ( Mean arterial pressure &lt; 65 mm Hg ; need vasopressor inotropic agent ; need mechanical circulatory support coronary intervention ) , NSTEMI evidence elevation troponin level ( Troponin &gt; 0.034 ng/ml ) ; renal failure serum creatinine &gt; 2.0 mg/dL 10. anemia HCT &lt; 30 % .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>